Health News

Adjuvant pembrolizumab beneficial in renal cell carcinoma

(HealthDay)—For patients with clear-cell renal cell carcinoma at high risk for recurrence after nephrectomy, adjuvant therapy with pembrolizumab improves disease-free survival, according to a study published in the Aug. 19 issue of the New England Journal of Medicine. Toni K. Choueiri, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues randomly assigned patients with […]

Health News

Response to adjuvant bevacizumab among patients with resected melanoma may vary by age

Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic bevacizumab (Avastin) while older patients with resected melanoma did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research. Preclinical data showed that VEGF, a protein that promotes angiogenesis and is the […]

Health Problems

Taxane + platinum feasible for adjuvant tx in endometrial cancer

(HealthDay)—Taxane plus platinum regimens may be a reasonable alternative to doxorubicin plus cisplatin as postoperative adjuvant chemotherapy for endometrial cancer that carries a high risk for progression, according to a study published online March 21 in JAMA Oncology. Hiroyuki Nomura, M.D., from the Keio University School of Medicine in Tokyo, and colleagues evaluated the clinical […]